tiprankstipranks
Trending News
More News >

Pharmarise Holdings Reports Increased Sales but Faces Profit Challenges

Story Highlights
Pharmarise Holdings Reports Increased Sales but Faces Profit Challenges

Elevate Your Investing Strategy:

Pharmarise Holdings Corp. ( (JP:2796) ) has issued an update.

Pharmarise Holdings Corporation reported a significant increase in net sales for the first nine months of the fiscal year ending May 31, 2025, with a 14.5% year-on-year growth. However, the company faced challenges with a substantial decline in operating profit and a net loss attributable to the owners, indicating potential operational difficulties. The financial results reflect a complex market environment, and the company has made changes in accounting policies and added a new company to its consolidation scope, which may impact future performance.

More about Pharmarise Holdings Corp.

Pharmarise Holdings Corporation operates in the pharmaceutical industry, focusing on the development and distribution of healthcare products. The company is listed on the Tokyo Stock Exchange and aims to enhance its market presence through strategic initiatives.

YTD Price Performance: -8.70%

Average Trading Volume: 19,842

Technical Sentiment Signal: Strong Buy

Current Market Cap: Yen5.68B

For detailed information about 2796 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1